Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06655636 · ClinicalTrials.gov registry record · NA
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
A NA study of Stroke and Cerebral Vascular Accident, sponsored by Shirley Ryan AbilityLab.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06655636: Recruiting NA study of Stroke and Cerebral Vascular Accident, sponsored by Shirley Ryan AbilityLab.
NCT06655636 is a NA study of Stroke and Cerebral Vascular Accident that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 30 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06655636, a NA study of Stroke and Cerebral Vascular Accident, is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the safety, feasibility, and efficacy of an exoskeletal network of passive, multi-joint springs for forearm supination. Also known as the forearm ExoNET, the device is a passive, robotic device that will properly assist forearm supination in the post-stroke adult population.
Primary Outcome
Observational measure used to assess change in upper extremity performance in individuals with a damaged nervous system
Conditions Studied
Interventions
- DEVICE Device tuned to Assistance
- DEVICE Device tuned to Sham (Slack Springs)
- DEVICE Device tuned to Anti-Assistance
Study Locations (1)
Illinois
- Shirley Ryan AbilityLab - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-12-04 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT06655636 shows while recruiting
NCT06655636 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 3 interventions - of which Device tuned to Assistance is the first listed.
NCT06655636 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06655636 about?
NCT06655636 is a clinical study titled "Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors". The purpose of this study is to evaluate the safety, feasibility, and efficacy of an exoskeletal network of passive, multi-joint springs for forearm supination. Also known as the forearm ExoNET, the device is a passive, robotic device that will properly assist forearm supination in the post-stroke a...
What is the current status of trial NCT06655636?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-12-04. Estimated completion is 2025-12.
What conditions does trial NCT06655636 study?
This clinical trial studies the following conditions: Stroke, Cerebral Vascular Accident.
What interventions are being tested in trial NCT06655636?
The interventions under investigation include: Device tuned to Assistance (DEVICE), Device tuned to Sham (Slack Springs) (DEVICE), Device tuned to Anti-Assistance (DEVICE).
Who is sponsoring clinical trial NCT06655636?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06655636 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06655636's enrollment target sits among peer trials
30 301st of 454 higher than 137 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Alternative Therapies for Improving Physical Function in Individuals With Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI